Vivani Medical (VANI) Form 3 SECOND SIGHT MEDICAL PRODUCTS / SCOTT DUNBAR ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

DUNBAR SCOTT

(Last) (First) (Middle)

13170 TELFAIR AVENUE

(Street)

SYLMAR CA 93142

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/30/2021

3. Issuer Name and Ticker or Trading Symbol
SECOND SIGHT MEDICAL PRODUCTS INC [ EYES ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Acting CEO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,383	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrants	03/06/2017	03/14/2024	Common Stock	935	11.76	D
Stock Options	03/01/2013	03/01/2022	Common Stock	775(1)	40	D
Stock Options	04/01/2015	04/01/2024	Common Stock	937(1)	40	D
Stock Options	09/26/2015	09/26/2024	Common Stock	5,305(1)	72	D
Stock Options	03/25/2016	03/25/2025	Common Stock	625(1)	104.72	D
Stock Options	01/21/2017	01/21/2026	Common Stock	1,151(1)	32.8	D
Stock Options	01/18/2018	01/18/2027	Common Stock	2,500(1)	13.84	D
Stock Options	04/02/2018	01/02/2028	Common Stock	2,500(2)	16.08	D
Stock Options	02/23/2019	01/23/2029	Common Stock	4,100(3)	6.52	D
Stock Options	03/12/2020	02/12/2030	Common Stock	4,125(3)	5.98	D

Explanation of Responses:

1. Options are fully vested and exercisable

2. The stock options have a 10-year term and vest over four years from the grant date in equal quarterly installments, subject to continuous employment, such that the total number of shares shall be fully vested on the four-year anniversary of the transaction date.

3. The stock options have a 10-year term and vest over four years from the grant date in equal monthly installments, subject to continuous employment, such that the total number of shares shall be fully vested on the four-year anniversary of the transaction date.

Remarks:

	/s/ Scott Dunbar	04/08/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.